Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-26 @ 2:13 AM
Study NCT ID:
NCT03531905
Status:
COMPLETED
Last Update Posted:
2020-04-09
First Post:
2018-05-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C
Sponsor:
Esperion Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-09
First Submit QC Date:
None
Study First Post Date:
2018-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-03-25
Results First Submit QC Date:
None
Results First Post Date:
2020-04-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-08
Last Update Post Date:
2020-04-09
Last Update Post Date Type:
ACTUAL